Microfluidic Systems
Pursuing what it sees as a burgeoning interest from investors and potential partners in increasingly smaller molecular diagnostic platforms, PositiveID has begun developing a battery-operated, handheld version of Dragonfly, its benchtop, cassette-based molecular testing system, t
IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Aug 3, 2011
Premium
Roche wins multiple US patents; Life Tech, Stanford, Medical Diagnostic Labs, PositiveID, and STMicroelectronics also awarded US patents.
The IP is assigned to Microfluidic Systems, which applied for the patent in September 2005 and is in the process of being acquired by PositiveID in a deal worth up to $8.2 million.
The deal, worth as much as $8.2 million, is expected to enable the medical-tech firm to expand into the biodefense and clinical diagnostics markets via MFSI's multiplexed molecular assays and automated, PCR-based sample-to-answer technology.